A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated

NCT04540874 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped due to company decision

Conditions

Healthy

Interventions

DRUG: BI 894416
DRUG: Placebo

Sponsor

Boehringer Ingelheim